Bipolar Affective Disorder Clinical Trials

7 recruitingLast updated: June 18, 2026

There are 7 actively recruiting bipolar affective disorder clinical trials across 4 countries. Studies span Not Applicable, Phase 2, Phase 3. Top locations include Beijing, Beijing Municipality, China, Frederiksberg, Denmark, Glostrup Municipality, Denmark. Updated daily from ClinicalTrials.gov.


Bipolar Affective Disorder Trials at a Glance

7 actively recruiting trials for bipolar affective disorder are listed on ClinicalTrialsFinder across 6 cities in 4 countries. The largest study group is Not Applicable with 2 trials, with the heaviest enrollment activity in Beijing, Frederiksberg, and Glostrup Municipality. Lead sponsors running bipolar affective disorder studies include Shanghai Mental Health Center, Bjorn H. Ebdrup, and Lars Vedel Kessing.

Browse bipolar affective disorder trials by phase

Treatments under study

About Bipolar Affective Disorder Clinical Trials

Looking for clinical trials for Bipolar Affective Disorder? There are currently 8 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Bipolar Affective Disorder trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Bipolar Affective Disorder clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 17 of 7 trials

Recruiting
Phase 2

Melatonin Versus Placebo for Bipolar Disorder

Bipolar Affective Disorder
Lars Vedel Kessing200 enrolled1 locationNCT07472075
Recruiting

Medical Phenotyping of NHS General Adult Psychiatry (GAP) Inpatients

Schizophrenia DisordersPersonality DisordersDepression Disorders+1 more
University of Edinburgh100 enrolled1 locationNCT07398365
Recruiting

Validation and Impact of Cardiorespiratory Fitness in Severe Mental Illness - the Heart in Mind Project

Bipolar Affective DisorderSevere Mental IllnessSchizophrenia Spectrum & Other Psychotic Disorders
Bjorn H. Ebdrup75 enrolled1 locationNCT06743711
Recruiting
Phase 3

Evaluation of the Efficacy, Safety, and Tolerability of Lacosamide in Major Depressive Episodes of Bipolar Disorder Types I and II.

Bipolar Affective Disorder
University of Sao Paulo40 enrolled1 locationNCT07412132
Recruiting
Not Applicable

Effectiveness of Digital Cognitive Behavioral Therapy for the Treatment of Depression: a Real-world Study

DepressionBipolar Affective DisorderSchizophenia Disorder+1 more
Peking University325 enrolled1 locationNCT06831435
Recruiting
Not Applicable

Prediction and Intervention Effect of Rehabilitation Status for Severe Mental Disorder Patients Based on Multimodal Analysis and AI Agents

SchizophreniaSevere Mental DisorderSchizoaffective Disorder+4 more
Shanghai Mental Health Center82 enrolled1 locationNCT06904079
Recruiting

A Study on the Preference of Risperidone Dosage Forms

SchizophreniaAutism Spectrum DisorderMental Retardation+2 more
Shanghai Mental Health Center1,000 enrolled1 locationNCT06657430